Sunday, September 13, 2026

Broadcom Drops 19.5%, NVIDIA Falls 6% as 2-Year Treasury Yield Hits 16-Month High

A five-day tech selloff erased hundreds of billions in market value, with Broadcom losing 19.5% and leveraged AI ETF FNGU falling 22%. The US 2-year Treasury yield spiked to a 16-month high on June 5, 2026 — the same day losses accelerated — even as AI earnings data remained intact.

LM Salvado
LM Salvado

June 9, 2026

Broadcom Drops 19.5%, NVIDIA Falls 6% as 2-Year Treasury Yield Hits 16-Month High
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Broadcom collapsed 19.5% between June 3–5, 2026, despite raising its Q3 FY26 AI semiconductor guidance.1 NVIDIA dropped 6% and Meta fell 6% on June 5 alone. The leveraged AI ETF FNGU lost 22% across the five-day window.1

The selloff coincided with the US 2-year Treasury yield spiking to its highest level in 16 months.1 Rate-sensitive growth equities bear the heaviest valuation impact from rising short-term yields. Discounted cash flow models compress sharply when the risk-free rate rises, punishing stocks priced on future earnings — precisely the profile of AI infrastructure plays.

Critically, AI demand signals did not deteriorate. Dell reported Q1 AI server order bookings of $24 billion and raised its full-year guidance to approximately $60 billion.1 Broadcom's own guidance increase confirms the AI capital expenditure cycle remains active. Earnings revisions stayed positive while stock prices fell — a divergence that points to rate sensitivity, not fundamental weakness, as the dominant driver.1

For portfolio managers, the episode sharpens a key risk: AI-exposed equities are now dual-beta instruments. They carry both AI adoption risk and duration risk. As long as the Fed's terminal rate path remains uncertain, high-multiple tech names will exhibit bond-like sensitivity to yield moves — regardless of underlying business momentum.

Investors overweight in AI semiconductors and infrastructure stocks face a reallocation question. Short-duration value names and dividend-paying industrials that benefit from AI buildout — without the valuation premium — may offer a more rate-resilient expression of the same thesis. The AI trade is intact; the risk premium attached to it has repriced.

The divergence between fundamentals and price action creates both a risk and an opportunity. If yields stabilize, the selloff gap between strong earnings and depressed prices may close quickly. If rate pressure continues, the multiple compression has further to run even as AI revenues grow.

In this story · Knowledge Files

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com